Indefinite Delivery Contract 36E79719D0029
Award Date 10/15/19
Last Date to Order 10/14/24
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Marlex Pharmaceuticals Inc. to provide baclofen tablets. The contract has a potential value of $17,702,067.50 and a period of performance from July 1, 2020, to June 30, 2025, with four one-year option periods. Marlex Pharmaceuticals Inc., a minority-owned and small disadvantaged business, is the sole provider of baclofen tablets under this contract. The agency estimates...
- This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
- The Department of Veterans Affairs (VA) awarded a $88 million Federal Supply Schedule (FSS) contract to Marlex Pharmaceuticals Inc., a minority-owned, self-certified small disadvantaged business located in New Castle, Delaware. The FSS contract, classified under FSS-61-IB Pharmaceuticals and Drugs, covers a period of 5 years through February 1, 2030. Under this FSS contract, Marlex Pharmaceuticals will supply a wide range of generic pharmaceutical products in tablet form to various federal...
- This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Marlex Pharmaceuticals Inc., a minority-owned and self-certified small disadvantaged business manufacturer of generic pharmaceutical and medical products. The $5.7 million contract covers the supply of alendronate tablets in different sizes to support the medical needs of the VA, Bureau of Prisons, and Indian Health Service. The contract has...
- Marlex Pharmaceuticals Inc., a minority-owned small disadvantaged business, has been awarded a single-award Indefinite Delivery Contract by the U.S. Defense Logistics Agency Troop Support Medical, a defense agency, with a ceiling value of $9,215,304.68 and an ultimate completion date of July 9, 2030. Under this IDC, Marlex Pharmaceuticals is the prime contractor responsible for manufacturing and distributing a wide range of generic pharmaceutical products, including tablets of prednisone,...
- The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Marlex Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract (36F79719D0161) is for the provision of pharmaceuticals and medical products under Schedule 65 I B, covering a wide range of generic drugs such as antibiotics, pain relievers, allergy treatments, muscle relaxants, and cardiovascular medications. The contract has a ceiling...
- The federal contract IDV award is for a single-award Indefinite Delivery Contract (IDC) with Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,787,656.00, is for the supply of Ropinirole HCL tablets in various dosages to the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The period of performance is from August 28, 2021, to August 27, 2022, with four one-year option...
- The Department of Veterans Affairs National Acquisition Center has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to supply methocarbamol tablets over a one-year base period and four one-year option periods. The contract has a total ceiling value of $11,608,273.60 and will support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program as well as the VA, Department of Defense, Bureau of Prisons,...
- The federal government, through the National Acquisition Center (NAC) of the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications. The $7,402,374.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of January 14, 2026. The contract aims to procure Amoxicillin/Clavulanate Tablets to meet the...
- This indefinite delivery contract was awarded by the National Acquisition Center, a civilian agency under the Department of Veterans Affairs (VA), to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract covers the procurement of Benazepril HCL tablets in various dosages, with an estimated annual requirement ranging from 867 bottles of 5mg tablets to 10,258 bottles of 20mg tablets. The contract has a base period of one year from November 6,...